The 41st Annual Cardiovascular Symposium at Dartmouth Hitchcock Medical Center

Thursday, October 10, 2024, 7:00 AM - 5:15 PM, Virtual and In Person at Dartmouth Hitchcock Medical Center, Lebanon, NH

AMA PRA Category 1 Credits™ (8.00 hours), CME-Designated Participation Credit (8.00 hours)

The 41st Annual Cardiovascular Symposium at Dartmouth offers continuing education in an interactive setting with experts in the field. A broad spectrum of topics in cardiovascular medicine will be covered with an emphasis on recent updates and challenging clinical scenarios relevant to a broad range of clinicians. Thank you for joining us for this unique educational experience.

1. Discuss a minimum of three recent updates in the care and treatment of patients with cardiovascular disease.
2. Discuss the role of genetics in the diagnosis and treatment of cardiovascular disease.
3. Demonstrate skills in the treatment of patients with postural tachycardia syndrome (POTS).
4. Summarize amyloid heart disease.
5. Explain new techniques in structural cardiology.
6. Describe the considerations in treating severe aortic stenosis surgically versus transcutaneously.
7. Summarize how left atrial appendage closure is a means of reducing stroke risk in atrial fibrillation.
8. Discuss the extent to which current STEMI has evolved over the last 60 years.
9. Review recent updates in vascular medicine.
10. Develop skills in diagnosing and treating pericardial disease.
11. Describe potential cardiovascular perils facing the pregnant patient.
12. Discuss diseases at the intersection of oncology and cardiology.
13. List the cardiac issues facing the patient living with HIV.
14. Review the treatment of acute MI beyond just the ST segment.
15. Discuss the extent to which data obtained for implanted devices can impact cardiologic care.

Online registration is now closed for this program. For late registration opportunities, please email Bethany Renaud.

 Registration is online and by credit card only. The registration fees are as follows:

In Person Attendance

• Dartmouth Health Advanced Practice Provider: $100.00
• Dartmouth Health MD: $125.00
• External Advanced Practice Provider: $125.00
• External MD: $150.00
• Other Medical Professionals: $150

Virtual Attendance

• All Professions: $75 

The registration deadline is 5 days prior to the activity date. There will be no refunds after that date. A $25 administrative fee will be retained on all refunds requested before the registration deadline. For registration questions, please email [email protected] or call (603) 653-1234.

In support of improving patient care, Dartmouth Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

American Medical Association (AMA)
Dartmouth Health designates this Live Activity for a maximum of 8.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All other learners may claim CME-designated participation credit. Consult your professional licensing board regarding the applicability and acceptance of CME-designated participation credit for programs certified for credit by organizations accredited by Joint Accreditation for Interprofessional Education. 

Receiving Credit
The following steps must be completed in order to receive credit for this event:

• Register for the event online
• Attend the event or session(s).  
• Complete the online evaluation (located under My Account in the top menu) - Must be submitted within 30 days after the activity

For questions or technical support, please email [email protected] or call (603) 653-1234.

Mitigation of Relevant Financial Relationships

Dartmouth Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education.  Any individuals in a position to control the content of a CE activity, including planners, faculty, authors, or others are required to disclose all financial relationships with ineligible companies^.  All relevant financial relationships have been mitigated prior to the commencement of the activity.

^Ineligible Company is any entity whose primary business purpose is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Thursday, October 10, 2024